Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Phlai capsule and loratadine as treatment in allergic rhinitis patients
TCTR20171111002Phase 3Enrolling by invitation
- Sponsor
- Thai Traditional Medicine Knowledge Fund
- Start
- May 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zingiber cassumunar, loratadine in allergic rhinitis (AR), sponsored by Thai Traditional Medicine Knowledge Fund. Started May 2017; status: enrolling by invitation.
02
Drugs
zingiber cassumunarloratadine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on TCTR20171111002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20171111002.